Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemoglobinopathies. Current therapeutic possibilities]

H S Birgens1, H Karle

  • 1Medicinsk-haematologisk afdeling L., Amtssygehuset i Herlev.

Ugeskrift for Laeger
|May 29, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Measuring the impact of a restrictive transfusion guideline in patients with acute myeloid leukaemia.

Vox sanguinis·2013
Same author

Chronic myeloid leukaemia with BCR-ABL fusion genes located to both chromosomes 9, cyclic leukocytosis and nodal T-lymphoblastic transformation--durable complete remission following imatinib therapy.

Leukemia·2005
Same author

[Renewal of medical education. Any difference?].

Ugeskrift for laeger·2001
Same author

[About Cochrane and use of albumin].

Ugeskrift for laeger·1999

The increasing immigrant population in Denmark has led to a rise in hemoglobinopathies, such as thalassemia and sickle cell anemia. This review covers current treatments and genetic counseling for these genetic blood disorders.

Area of Science:

  • Hematology
  • Medical Genetics
  • Public Health

Background:

  • Denmark is experiencing a significant increase in its immigrant population.
  • This demographic shift introduces new genetic diseases into the healthcare system.
  • Immigrants often originate from regions with high gene frequencies for hemoglobinopathies.

Observation:

  • The prevalence of heterozygous thalassemias is most common.
  • There is a notable increase in severe thalassemia and sickle cell anemia cases.
  • Clinical management focuses on genetic counseling, prenatal diagnostics, and treatment of severe forms.

Findings:

  • Allogeneic bone marrow transplantation is the only cure for hemoglobinopathies but is limited in availability.
  • Various therapeutic strategies can enhance the prognosis and quality of life for affected patients.

Related Experiment Videos

  • The number of patients with these genetic blood disorders is projected to rise.

    • Implications:

    • Healthcare providers need to be prepared for an increasing number of patients with hemoglobinopathies.
    • Effective genetic counseling and diagnostic services are crucial.
    • Further research into and accessibility of therapeutic options are necessary to improve patient outcomes.